Per Odin

Lund University

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

ORCID

Google Scholar

Academic Page

Articles (30)

Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease

Article Link

Year:

2025

Conversion between NMSS and MDS‐NMS in Parkinson's Disease

Article Link

Year:

2025

Recognition, management, and patient perspectives of impulsive-compulsive disorders in Parkinson’s disease

Article Link

Year:

2025

Ethnographic evaluation of usability, understandability, and acceptance of the MY PD-CARE digital tool to facilitate Parkinson’s disease symptom tracking and patients’ and care partners’ communications with the treating healthcare professional: the SELF-AWARE study

Article Link

Year:

2025

Authors’ reply to Chaker Ben Salem’s comment on: “Drug-Induced Cognitive Impairment”

Article Link

Year:

2025

Simultaneous Nonmotor Symptoms Do Not Affect General Validity but Interpretation of the Parkinson's Disease Motor Diary

Article Link

Year:

2025

Early thinking palliative care for people with Parkinson's disease: A thematic synthesis based on a systematic mixed-methods review

Article Link

Year:

2025

Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study

Article Link

Year:

2025

The association between non-motor symptoms and cost in Parkinson’s disease

Article Link

Year:

2025

Personality Trait Changes After Device‐Aided Therapy: Insights From Parkinson’s Patients and Their Close Relatives

Article Link

Year:

2025

Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

Article Link

Year:

2024

Care of Late-Stage Parkinsonism

Article Link

Year:

2024

Non-Motor Symptom Management

Article Link

Year:

2024

Economic Burden of Parkinson’s Disease

Article Link

Year:

2024

Meaning in Life in Late-Stage Parkinson’s Disease

Article Link

Year:

2024

The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson’s Disease

Article Link

Year:

2024

Time to workforce exit after a Parkinson’s disease diagnosis

Article Link

Year:

2023

Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration

Article Link

Year:

2023

Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training

Article Link

Year:

2023

A systematic practice review: Providing palliative care for people with Parkinson’s disease and their caregivers

Article Link

Year:

2023

A Paradigm Shift in the Management of Patients with Parkinson's Disease

Article Link

Year:

2023

Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson's disease

Article Link

Year:

2023

Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment

Article Link

Year:

2023

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease

Article Link

Year:

2022

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis

Article Link

Year:

2022

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

Article Link

Year:

2022

High risk of developing dementia in Parkinson’s disease

Article Link

Year:

2022

Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain

Article Link

Year:

2022

Safinamide in the treatment pathway of Parkinson’s Disease

Article Link

Year:

2022

Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson's disease

Article Link

Year:

2022

Collaborators (20)

Nicola Pavese

Aarhus University

DENMARK

Piret Paal

Paracelsus Medical University

AUSTRIA

Aristide Merola

Associate Professor of Neurology

Ohio State University

UNITED STATES

David Brooks

Aarhus University

DENMARK

Carin Janz

Lund University

SWEDEN

K Ray Chaudhuri

King’s College London

UNITED KINGDOM

Valentina Leta

King's College Hospital

UNITED KINGDOM

Mezin Öthman

Uppsala University

SWEDEN

Anette Schrag

University College London

UNITED KINGDOM

Ioanna Markaki

Karolinska Institutet

SWEDEN

Richard Brown

King’s College London

UNITED KINGDOM

Daniel Weintraub

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

Per Borghammer

Aarhus University

DENMARK

Angelo Antonini

Full Professor

University of Padova

ITALY

Jaime Kulisevsky

SPAIN

Susanne Iwarsson

Professor

Lund University

SWEDEN

Dag Nyholm

Professor of Neurology

Uppsala University

SWEDEN

Simon J.G. Lewis

AUSTRALIA

Andreas Jakobsson

Lund University

SWEDEN

Arne Reimers

Head

Region Skåne

SWEDEN

Per Odin

Research Interests

Explore related searches

Contact this professor

Articles (30)

Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease

Conversion between NMSS and MDS‐NMS in Parkinson's Disease

Recognition, management, and patient perspectives of impulsive-compulsive disorders in Parkinson’s disease

Ethnographic evaluation of usability, understandability, and acceptance of the MY PD-CARE digital tool to facilitate Parkinson’s disease symptom tracking and patients’ and care partners’ communications with the treating healthcare professional: the SELF-AWARE study

Authors’ reply to Chaker Ben Salem’s comment on: “Drug-Induced Cognitive Impairment”

Simultaneous Nonmotor Symptoms Do Not Affect General Validity but Interpretation of the Parkinson's Disease Motor Diary

Early thinking palliative care for people with Parkinson's disease: A thematic synthesis based on a systematic mixed-methods review

Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study

The association between non-motor symptoms and cost in Parkinson’s disease

Personality Trait Changes After Device‐Aided Therapy: Insights From Parkinson’s Patients and Their Close Relatives

Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

Care of Late-Stage Parkinsonism

Non-Motor Symptom Management

Economic Burden of Parkinson’s Disease

Meaning in Life in Late-Stage Parkinson’s Disease

The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson’s Disease

Time to workforce exit after a Parkinson’s disease diagnosis

Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration

Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training

A systematic practice review: Providing palliative care for people with Parkinson’s disease and their caregivers

A Paradigm Shift in the Management of Patients with Parkinson's Disease

Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson's disease

Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

High risk of developing dementia in Parkinson’s disease

Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain

Safinamide in the treatment pathway of Parkinson’s Disease

Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson's disease

Collaborators (20)

Nicola Pavese

Piret Paal

Aristide Merola

David Brooks

Carin Janz

K Ray Chaudhuri

Valentina Leta

Mezin Öthman

Anette Schrag

Ioanna Markaki

Richard Brown

Daniel Weintraub

Per Borghammer

Angelo Antonini

Jaime Kulisevsky

Susanne Iwarsson

Dag Nyholm

Simon J.G. Lewis

Andreas Jakobsson

Arne Reimers

How do I reach out?

Meet Kite AI